MedCity News January 7, 2024
A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers’ tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.
The last year was a big one for payers, with several major M&A deals, according to a recent report from KPMG. This includes CVS Health’s $8 billion purchase of Signify Health and $10.6 billion purchase of Oak Street Health, as well as UnitedHealth Group’s Optum’s $3.3 billion acquisition of Amedisys. In 2024, payers “will become ever more important in the U.S. healthcare system,” KPMG said.
But there are several challenges ahead as well, such as regulatory pressures against Medicare Advantage and pharmacy benefit managers.
Here are KPMG’s five tailwinds and five headwinds for...
Today's Sponsors
Today's Sponsor